Discovery of Anti-Alzheimer agents: Current Ligand-Based approaches toward the design of acetylcholinesterase inhibitors

Mini-Reviews in Medicinal Chemistry

Volumn 12, Issue 6, 2012, Pages 583-591

  Speck Planche, A ^a   Luan, F ^a,b   Cordeiro, M N D S ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b YANTAI UNIVERSITY   (China)

Author keywords

3D QSAR; AChE inhibitors; Fragments; Linear discriminant analysis; QSAR

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; RIVASTIGMINE;

ALZHEIMER DISEASE; ARTICLE; DRUG DESIGN; DRUG ISOLATION; DRUG MECHANISM; HUMAN; LIGAND BASED DRUG DESIGN; STRUCTURE ACTIVITY RELATION;

EID: 84861123157     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955712800493744     Document Type: Article

References (84)

1. Geula, C.; Mesulam, M.M. Cholinesterases and the pathology of Alzheimer disease. Alzheimer Dis. Assoc. Disord., 1995, 9(Suppl 2), 23-28.
2. Stahl, S.M.; Markowitz, J.S.; Gutterman, E.M.; Papadopoulos, G. Co-use of donepezil and hypnotics among Alzheimer's disease patients living in the community. J. Clin. Psychiatry, 2003, 64(4), 466-472.
3. Brookmeyer, R.; Gray, S.; Kawas, C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am. J. Public Health, 1998, 88(9), 1337-1342.
4. Bermejo-Pareja, F.; Benito-Leon, J.; Vega, S.; Medrano, M.J.; Roman, G.C. Incidence and subtypes of dementia in three elderly populations of central Spain. J. Neurol. Sci., 2008, 264(1-2), 63-72.
5. Luo, W.; Li, Y.P.; Tan, J.H.; Gu, L.Q.; Huang, Z.S. Synthesis and biological evaluation of novel N, N'-bis-methylenedioxybenzylalkylenediamines as bivalent anti-Alzheimer disease ligands. J. Enzyme Inhib. Med. Chem., 2011, 26(5), 706-711.
6. Min, B.S.; Cuong, T.D.; Lee, J.S.; Shin, B.S.; Woo, M.H.; Hung, T.M. Cholinesterase inhibitors from Cleistocalyx operculatus buds. Arch. Pharm. Res., 2010, 33(10), 1665-1670.
7. Jin, Z.; Yang, L.; Liu, S.J.; Wang, J.; Li, S.; Lin, H.Q.; Wan, D.C.; Hu, C. Synthesis and biological evaluation of 3,6-diaryl-7Hthiazolo[3,2-b] [1,2,4]triazin-7-one derivatives as acetylcholinesterase inhibitors. Arch. Pharm. Res., 2010, 33(10), 1641-1649.
8. Ali, M.A.; Ismail, R.; Choon, T.S.; Yoon, Y.K.; Wei, A.C.; Pandian, S.; Kumar, R.S.; Osman, H.; Manogaran, E. Substituted spiro [2.3'] oxindolespiro [3.2″]-5,6-dimethoxy-indane-1″-onepyrrolidine analogue as inhibitors of acetylcholinesterase. Bioorg. Med. Chem. Lett., 2010, 20(23), 7064-7066.
9. Kwon, S.H.; Lee, H.K.; Kim, J.A.; Hong, S.I.; Kim, H.C.; Jo, T.H.; Park, Y.I.; Lee, C.K.; Kim, Y.B.; Lee, S.Y.; Jang, C.G. Neuroprotective effects of chlorogenic acid on scopolamineinduced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice. Eur. J. Pharmacol., 2010, 649(1-3), 210-217.
10. de Los Rios, C.; Egea, J.; Marco-Contelles, J.; Leon, R.; Samadi, A.; Iriepa, I.; Moraleda, I.; Galvez, E.; Garcia, A.G.; Lopez, M.G.; Villarroya, M.; Romero, A. Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives. J. Med. Chem., 2010, 53(14), 5129-5143.
11. Geissler, T.; Brandt, W.; Porzel, A.; Schlenzig, D.; Kehlen, A.; Wessjohann, L.; Arnold, N. Acetylcholinesterase inhibitors from the toadstool Cortinarius infractus. Bioorg. Med. Chem., 2010, 18(6), 2173-2177.
12. Zhang, L.J.; Xiao, Y.; Qi, X.L.; Shan, K.R.; Pei, J.J.; Kuang, S.X.; Liu, F.; Guan, Z.Z. Cholinesterase activity and mRNA level of nicotinic acetylcholine receptors (alpha4 and beta2 subunits) in blood of elderly Chinese diagnosed as Alzheimer's disease. J. Alzheimers Dis., 2010, 19(3), 849-858.
13. Araujo, J.Q.; de Brito, M.A.; Hoelz, L.V.; de Alencastro, R.B.; Castro, H.C.; Rodrigues, C.R.; Albuquerque, M.G. Receptordependent (RD) 3D-QSAR approach of a series of benzylpiperidine inhibitors of human acetylcholinesterase (HuAChE). Eur. J. Med. Chem., 2011, 46(1), 39-51.
14. Ul-Haq, Z.; Mahmood, U.; Jehangir, B. Ligand-based 3D-QSAR studies of physostigmine analogues as acetylcholinesterase inhibitors. Chem. Biol. Drug Des., 2009, 74(6), 571-581.
15. Solomon, K.A.; Sundararajan, S.; Abirami, V. QSAR studies on Naryl derivative activity towards Alzheimer's disease. Molecules, 2009, 14(4), 1448-1455.
16. Bruhlmann, C.; Marston, A.; Hostettmann, K.; Carrupt, P.A.; Testa, B. Screening of non-alkaloidal natural compounds as acetylcholinesterase inhibitors. Chem. Biodivers., 2004, 1(6), 819-829.
17. Bruhlmann, C.; Ooms, F.; Carrupt, P.A.; Testa, B.; Catto, M.; Leonetti, F.; Altomare, C.; Carotti, A. Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase. J. Med. Chem., 2001, 44(19), 3195-3198.
18. Kaur, J.; Zhang, M.Q. Molecular modelling and QSAR of reversible acetylcholinesterase inhibitors. Curr. Med. Chem., 2000, 7(3), 273-294.
19. Sippl, W.; Contreras, J.M.; Parrot, I.; Rival, Y.M.; Wermuth, C.G. Structure-based 3D QSAR and design of novel acetylcholinesterase inhibitors. J. Comput. Aided Mol. Des., 2001, 15(5), 395-410.
20. Recanatini, M.; Cavalli, A.; Hansch, C. A comparative QSAR analysis of acetylcholinesterase inhibitors currently studied for the treatment of Alzheimer's disease. Chem. Biol. Interact., 1997, 105(3), 199-228.
21. Sopkova-de Oliveira Santos, J.; Lesnard, A.; Agondanou, J.H.; Dupont, N.; Godard, A.M.; Stiebing, S.; Rochais, C.; Fabis, F.; Dallemagne, P.; Bureau, R.; Rault, S. Virtual screening discovery of new acetylcholinesterase inhibitors issued from CERMN chemical library. J. Chem. Inf. Model., 2010, 50(3), 422-428.
22. Golbraikh, A.; Bernard, P.; Chretien, J.R. Validation of proteinbased alignment in 3D quantitative structure-activity relationships with CoMFA models. Eur. J. Med. Chem., 2000, 35(1), 123-136.
23. Kubinyi, H. QSAR: Hansch Analysis and Related Approaches, VCH Publishers: Weinheim, New York, Basel, Cambridge, Tokyo, 1993.
24. van de Waterbeemd, H. Advanced Computer-Assisted Techniques in Drug Discovery, VCH Publishers: Weinheim, New York, Basel, Cambridge, Tokyo, 1995.
25. Pastor, M.; Cruciani, G.; Watson, K.A. A strategy for the incorporation of water molecules present in a ligand binding site into a three-dimensional quantitative structure--activity relationship analysis. J. Med. Chem., 1997, 40(25), 4089-102.
26. Nilsson, J.; Wikstrom, H.; Smilde, A.; Glase, S.; Pugsley, T.; Cruciani, G.; Pastor, M.; Clementi, S. GRID/GOLPE 3D quantitative structure-activity relationship study on a set of benzamides and naphthamides, with affinity for the dopamine D3 receptor subtype. J. Med. Chem., 1997, 40(6), 833-840.
27. van de Waterbeemd, H. Chemometrics Methods in Molecular Design, VCH Publishers: Weinheim, New York, Basel, Cambridge, Tokyo, 1995.
28. Estrada, E. Protein bipartivity and essentiality in the yeast proteinprotein interaction network. J. Proteome Res., 2006, 5(9), 2177-2184.
29. Estrada, E. Virtual identification of essential proteins within the protein interaction network of yeast. Proteomics, 2006, 6(1), 35-40.
30. Prado-Prado, F.J.; Gonzalez-Diaz, H.; de la Vega, O.M.; Ubeira, F.M.; Chou, K.C. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds. Bioorg. Med. Chem., 2008, 16(11), 5871-5880.
31. Prado-Prado, F.J.; Martinez de la Vega, O.; Uriarte, E.; Ubeira, F.M.; Chou, K.C.; Gonzalez-Diaz, H. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks. Bioorg. Med. Chem., 2009, 17(2), 569-575.
32. Munteanu, C.R.; Vazquez, J.M.; Dorado, J.; Sierra, A.P.; Sanchez-Gonzalez, A.; Prado-Prado, F.J.; Gonzalez-Diaz, H. Complex network spectral moments for ATCUN motif DNA cleavage: first predictive study on proteins of human pathogen parasites. J. Proteome Res., 2009, 8(11), 5219-5228.
33. Vina, D.; Uriarte, E.; Orallo, F.; Gonzalez-Diaz, H. Alignment-free prediction of a drug-target complex network based on parameters of drug connectivity and protein sequence of receptors. Mol. Pharm., 2009, 6(3), 825-835.
34. Garcia, I.; Munteanu, C.R.; Fall, Y.; Gomez, G.; Uriarte, E.; Gonzalez-Diaz, H. QSAR and complex network study of the chiral HMGR inhibitor structural diversity. Bioorg. Med. Chem., 2009, 17(1), 165-175.
35. Fernandez, M.; Tundidor-Camba, A.; Caballero, J. Modeling of cyclin-dependent kinase inhibition by 1H-pyrazolo[3,4-d]pyrimidine derivatives using artificial neural network ensembles. J. Chem. Inf. Model., 2005, 45(6), 1884-1895.
36. Gonzalez, M.P.; Caballero, J.; Helguera, A.M.; Garriga, M.; Gonzalez, G.; Fernandez, M. 2D autocorrelation modelling of the inhibitory activity of cytokinin-derived cyclin-dependent kinase inhibitors. Bull. Math. Biol., 2006, 68(4), 735-751.
37. Caballero, J.; Fernandez, M. Linear and nonlinear modeling of antifungal activity of some heterocyclic ring derivatives using multiple linear regression and bayesian-regularized neural networks. J. Mol. Model., 2006, 12(2), 168-181.
38. Caballero, J.; Fernandez, L.; Abreu, J.I.; Fernandez, M. Amino acid sequence autocorrelation vectors and ensembles of bayesianregularized genetic neural networks for prediction of conformational stability of human lysozyme mutants. J. Chem. Inf. Model., 2006, 46(3), 1255-1268.
39. Caballero, J.; Fernandez, L.; Garriga, M.; Abreu, J.I.; Collina, S.; Fernandez, M. Proteometric study of ghrelin receptor function variations upon mutations using amino acid sequence autocorrelation vectors and genetic algorithm-based least square support vector machines. J. Mol. Graph. Model., 2007, 26(1), 166-178.
40. Goulon, A.; Picot, T.; Duprat, A.; Dreyfus, G. Predicting activities without computing descriptors: graph machines for QSAR. SAR QSAR Environ. Res., 2007, 18(1-2), 141-153.
41. Du, H.; Wang, J.; Hu, Z.; Yao, X.; Zhang, X. Prediction of fungicidal activities of rice blast disease based on least-squares support vector machines and project pursuit regression. J. Agric Food. Chem., 2008, 56(22), 10785-1092.
42. Munteanu, C.R.; Gonzalez-Diaz, H.; Magalhaes, A.L. Enzymes/non-enzymes classification model complexity based on composition, sequence, 3D and topological indices. J. Theor. Biol., 2008, 254(2), 476-482.
43. Tetko, I.V.; Sushko, I.; Pandey, A.K.; Zhu, H.; Tropsha, A.; Papa, E.; Oberg, T.; Todeschini, R.; Fourches, D.; Varnek, A. Critical assessment of QSAR models of environmental toxicity against Tetrahymena pyriformis: focusing on applicability domain and overfitting by variable selection. J. Chem. Inf. Model., 2008, 48(9), 1733-1746.
44. CERMNdatabase. Available at: http://www.cermn.unicaen.fr/. 2010.
45. Speck-Planche, A.; Scotti, M.T.; García-López, A.; Emerenciano, V.P.; Molina-Pérez, E.; Uriarte, E. Design of novel antituberculosis compounds using graph-theoretical and substructural approaches. Mol. Divers., 2009, 13(4), 445-458.
46. Speck-Planche, A.; Scotti, M.T.; Emerenciano, V.P.; García-López, A.; Molina-Pérez, E.; Uriarte, E. Designing novel antitrypanosomal agents from a mixed graph-theoretical substructural approach. J. Comput. Chem., 2010, 31(4), 882-894.
47. Viswanadhan, V.N.; Ghose, A.K.; Revankar, G.R.; Robins, R.K. Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics. J. Chem. Inf. Comput. Sci., 1989, 29(3), 163-172.
48. Speck-Planche, A.; Guilarte-Montero, L.; Yera-Bueno, R.; Rojas-Vargas, J.A.; Garcia-Lopez, A.; Uriarte, E.; Molina-Perez, E. Rational design of new agrochemical fungicides using substructural descriptors. Pest Manag. Sci., 2011, 67(4), 438-445.
49. Estrada, E.; Gutierrez, Y. Modeling chromatographic parameters by a novel graph theoretical sub-structural approach. J. Chromatogr. A, 1999, 858(2), 187-199.
50. Estrada, E.; Gutierrez, Y.; Gonzalez, H. Modeling diamagnetic and magnetooptic properties of organic compounds with the TOSSMODE approach. J. Chem. Inf. Comput. Sci., 2000, 40(6), 1386-1399.
51. Estrada, E. A computer-based approach to describe the 13C NMR chemical shifts of alkanes by the generalized spectral moments of iterated line graphs. Comput. Chem., 2000, 24(2), 193-201.
52. Estrada, E.; Uriarte, E. Quantitative structure-toxicity relationships using TOPS-MODE. 1. Nitrobenzene toxicity to Tetrahymena pyriformis. SAR QSAR Environ. Res., 2001, 12(3), 309-324.
53. Estrada, E.; Uriarte, E.; Gutierrez, Y.; Gonzalez, H. Quantitative structure-toxicity relationships using TOPS-MODE. 3. Structural factors influencing the permeability of commercial solvents through living human skin. SAR QSAR Environ. Res., 2003, 14(2), 145-163.
54. Helguera, A.M.; Gonzalez, M.P.; Cordeiro, M.N.D.S.; Perez, M.A.C. Quantitative structure carcinogenicity relationship for detecting structural alerts in nitroso-compounds. Toxicol. Appl. Pharmacol., 2007, 221(2), 189-202.
55. Helguera, A.M.; Cordeiro, M.N.D.S.; Perez, M.A.C.; Combes R.D.; Gonzalez, M.P. Quantitative structure carcinogenicity relationship for detecting structural alerts in nitroso-compounds species, rat; sex, female; route of administration, water. Toxicol. Appl. Pharmacol., 2008, 231(2), 197-207.
56. Helguera, A.M.; Gonzalez, M.P.; Cordeiro, M.N.D.S.; Perez, M.A.C. Quantitative structure-carcinogenicity relationship for detecting structural alerts in nitroso-compounds: species, rat; sex, female; route of administration, gavage. Chem. Res. Toxicol., 2008, 21(3), 633-642.
57. Helguera, A.M.; Perez-Machado, G.; Cordeiro, M.N.D.S.; Combes, R.D. Quantitative structure-activity relationship modelling of the carcinogenic risk of nitroso compounds using regression analysis and the TOPS-MODE approach. SAR QSAR Environ. Res., 2010, 21(3-4), 277-304.
58. Estrada, E.; Vilar, S.; Uriarte, E.; Gutierrez, Y. In silico studies toward the discovery of new anti-HIV nucleoside compounds with the use of TOPS-MODE and 2D/3D connectivity indices. 1. Pyrimidyl derivatives. J. Chem. Inf. Comput. Sci., 2002, 42(5), 1194-1203.
59. Vilar, S.; Estrada, E.; Uriarte, E.; Santana, L.; Gutierrez, Y. In silico studies toward the discovery of new anti-HIV nucleoside compounds through the use of TOPS-MODE and 2D/3D connectivity indices. 2. Purine derivatives. J. Chem. Inf. Model., 2005, 45(2), 502-514.
60. Estrada, E.; Quincoces, J.A.; Patlewicz, G. Creating molecular diversity from antioxidants in Brazilian propolis. Combination of TOPS-MODE QSAR and virtual structure generation. Mol. Divers., 2004, 8(1), 21-33.
61. Estrada, E. Spectral moments of the edge adjacency matrix in molecular graphs. 1. Definition and applications for the prediction of physical properties of alkanes. J. Chem. Inf. Comput. Sci., 1996, 36(4), 844-849.
62. Estrada, E. Spectral moments of the edge adjacency matrix in molecular graphs. 2. Molecules containing heteroatoms and QSAR applications. J. Chem. Inf. Comput. Sci., 1997, 37(2), 320-328.
63. Estrada, E. Spectral moments of the edge adjacency matrix in molecular graphs. 3. Molecules containing cycles. J. Chem. Inf. Comput. Sci., 1998, 38(1), 23-27.
64. Estrada, E.; Uriarte, E.; Montero, A.; Teijeira, M.; Santana, L.; De Clercq, E. A novel approach for the virtual screening and rational design of anticancer compounds. J. Med. Chem., 2000, 43(10), 1975-1985.
65. Estrada, E.; Molina, E.; Perdomo-Lopez, I. Can 3D structural parameters be predicted from 2D (topological) molecular descriptors? J. Chem. Inf. Comput. Sci., 2001, 41(4), 1015-1021.
66. ChEMBL Database. http://www.ebi.ac.uk/chembldb/. 2010.
67. O'Neill, M.J.; Heckelman, P.E.; Koch, C.B.; Roman, K.J. The Merck Index, An Encyclopedia of Chemicals, Drugs and Biologicals, 14th ed.; Whitehouse Station, NJ: Merck & Co., Inc: New Jersey, 2006.
68. Talete-srl. DRAGON for Windows (Software for Molecular Descriptor Calculations), v5.3; Milano Chemometrics and QSAR Research Group: Milano, 2005.
69. Estrada, E.; Gutiérrez, Y. MODESLAB, v1.5; Santiago de Compostela, 2002-2004.
70. Casañola-Martin, G.M.; Marrero-Ponce, Y.; Khan, M.T.; Khan, S.B.; Torrens, F.; Perez-Jimenez, F.; Rescigno, A.; Abad, C. Bondbased 2D quadratic fingerprints in QSAR studies: virtual and in vitro tyrosinase inhibitory activity elucidation. Chem. Biol. Drug Des., 2010, 76(6), 538-545.
71. Sun, M.; Chen, J.; Wei, H.; Yin, S.; Yang, Y.; Ji, M. Quantitative structure-activity relationship and classification analysis of diaryl ureas against vascular endothelial growth factor receptor-2 kinase using linear and non-linear models. Chem. Biol. Drug Des., 2009, 73(6), 644-654.
72. Prado-Prado, F.J.; Garcia-Mera, X.; Gonzalez-Diaz, H. Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorg. Med. Chem., 2010, 18(6), 2225-2231.
73. Munteanu, C.R.; Magalhaes, A.L.; Uriarte, E.; Gonzalez-Diaz, H. Multi-target QPDR classification model for human breast and colon cancer-related proteins using star graph topological indices. J. Theor. Biol., 2009, 257(2), 303-311.
74. Munteanu, C.R.; Gonzalez-Diaz, H.; Borges, F.; de Magalhaes, A.L. Natural/random protein classification models based on star network topological indices. J. Theor. Biol., 2008, 254(4), 775-783.
75. Gonzalez-Diaz, H.; Molina, R.; Uriarte, E. Recognition of stable protein mutants with 3D stochastic average electrostatic potentials. FEBS Lett., 2005, 579(20), 4297-4301.
76. StatSoft. STATISTICA. Data Analysis Software System, v6.0; Tulsa, 2001.
77. Hanczar, B.; Hua, J.; Sima, C.; Weinstein, J.; Bittner, M.; Dougherty, E.R. Small-sample precision of ROC-related estimates. Bioinformatics, 2010, 26(6), 822-830.
78. Speck-Planche, A.; Kleandrova, V.V.; Luan, F.; Cordeiro, M.N.D.S. Multi-target drug discovery in anti-cancer therapy: fragment-based approach toward the design of potent and versatile anti-prostate cancer agents. Bioorg. Med. Chem., 2011, 19(21), 6239-6244.
79. Speck-Planche, A.; Cordeiro, M.N.D.S. Application of Bioinformatics for the search of novel anti-viral therapies: rational design of anti-herpes agents. Curr. Bioinform., 2011, 6(1), 81-93.
80. Speck-Planche, A.; Kleandrova, V.V.; Luan, F.; Cordeiro, M.N.D.S. Fragment-based QSAR model toward the selection of versatile anti-sarcoma leads. Eur. J. Med. Chem., 2011, 46(12), 5910-5916.
81. Prado-Prado, F.J.; Borges, F.; Uriarte, E.; Perez-Montoto, L.G.; Gonzalez-Diaz, H. Multi-target spectral moment: QSAR for antiviral drugs vs. different viral species. Anal. Chim. Acta, 2009, 651(2), 159-164.
82. Prado-Prado, F.J.; Borges, F.; Perez-Montoto, L.G.; Gonzalez-Diaz, H. Multi-target spectral moment: QSAR for antifungal drugs vs. different fungi species. Eur. J. Med. Chem., 2009, 44(10), 4051-4056.
83. Prado-Prado, F.J.; Uriarte, E.; Borges, F.; Gonzalez-Diaz, H. Multitarget spectral moments for QSAR and complex networks study of antibacterial drugs. Eur. J. Med. Chem., 2009, 44(11), 4516-4521.
84. Montero-Torres, A.; Vega, M.C.; Marrero-Ponce, Y.; Rolón, M.; Gómez-Barrio, A.; Escario, J.A. A novel non-stochastic quadratic fingerprints-based approach for the 'in silico' discovery of new antitrypanosomal compounds. Bioorg. Med. Chem., 2005, 13(22), 6264-6275.